Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02549209
Title Pembro/Carbo/Taxol in Endometrial Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mario Javier Pineda, MD
Indications

endometrial carcinoma

Therapies

Carboplatin + Paclitaxel + Pembrolizumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Ironwood Cancer and Research Centers Mesa Arizona 85206 United States Details
Northwestern University, Robert H. Lurie Cancer Center Chicago Illinois 60611 United States Details
Northwestern Medicine Lake Forest Hospital Lake Forest Illinois 60045 United States Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field